High Prevalence of Hepatitis C Infection in Afro‐Caribbean Patients with Type 2 Diabetes and Abnormal Liver Function Tests
High Prevalence of Hepatitis C Infection in Afro‐Caribbean Patients with Type 2 Diabetes and Abnormal Liver Function Tests
Moderate elevations of serum transaminases are frequently found in patients with diabetes mellitus and are often attributed to fatty infiltration of the liver without further investigation. Recent studies of patients with end‐stage liver disease have suggested a possible association between Hepatitis C virus (HCV) antibody positivity and the development of diabetes (mostly Type 2). As a first step in the examination of any potential association between HCV and Type 2 diabetes in subjects without overt liver disease, we examined 200 British patients with Type 2 diabetes (100 White Caucasians, 50 Asians, and 50 Afro‐Caribbeans), recruited from the United Kingdom Prospective Study of Diabetes, half of whom had a significant elevation of alanine aminotransferase (ALT) on at least two occasions and half of whom had consistently normal ALT levels. In Afro‐Caribbean Type 2 diabetic subjects 7/25 (28%) patients with abnormal ALT and 1/25 (4%) with normal ALT were HCV antibody positive. Among White Caucasian subjects 6/50 (12%) patients with abnormal LFTs and 0/50 with normal LFTs were HCV antibody positive and in Asians the prevalence was 2/25 (8%) and 0/25, respectively. This study suggests that persistent mild to moderate elevation of serum transaminases in a patient with Type 2 diabetes should not automatically be attributed to the metabolic disturbances of diabetes. Particularly in Afro‐Caribbean subjects, HCV infection is a major diagnostic consideration. The question of whether HCV infection itself may have a diabetogenic action is worthy of further investigation. 1995 Diabetes UK
Hepatitis C, Liver function tests, Type 2 Diabetes
244-249
Gray, H.
a178432f-8d0b-4249-ad06-716b3ad46b4e
Wreghitt, T.
7770101b-fd7e-406a-a541-ae477474e4e1
Stratton, I. M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Alexander, G. J.M.
fe8f2cae-428a-4449-bf09-1ecd4078bd19
Turner, R. C.
9c4a3b92-5186-43ae-b750-08990e742e4e
O'Rahilly, S.
4dbefabf-bb9d-4784-9a0a-54f8e413a7bb
March 1995
Gray, H.
a178432f-8d0b-4249-ad06-716b3ad46b4e
Wreghitt, T.
7770101b-fd7e-406a-a541-ae477474e4e1
Stratton, I. M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Alexander, G. J.M.
fe8f2cae-428a-4449-bf09-1ecd4078bd19
Turner, R. C.
9c4a3b92-5186-43ae-b750-08990e742e4e
O'Rahilly, S.
4dbefabf-bb9d-4784-9a0a-54f8e413a7bb
Gray, H., Wreghitt, T., Stratton, I. M., Alexander, G. J.M., Turner, R. C. and O'Rahilly, S.
(1995)
High Prevalence of Hepatitis C Infection in Afro‐Caribbean Patients with Type 2 Diabetes and Abnormal Liver Function Tests.
Diabetic Medicine, 12 (3), .
(doi:10.1111/j.1464-5491.1995.tb00466.x).
Abstract
Moderate elevations of serum transaminases are frequently found in patients with diabetes mellitus and are often attributed to fatty infiltration of the liver without further investigation. Recent studies of patients with end‐stage liver disease have suggested a possible association between Hepatitis C virus (HCV) antibody positivity and the development of diabetes (mostly Type 2). As a first step in the examination of any potential association between HCV and Type 2 diabetes in subjects without overt liver disease, we examined 200 British patients with Type 2 diabetes (100 White Caucasians, 50 Asians, and 50 Afro‐Caribbeans), recruited from the United Kingdom Prospective Study of Diabetes, half of whom had a significant elevation of alanine aminotransferase (ALT) on at least two occasions and half of whom had consistently normal ALT levels. In Afro‐Caribbean Type 2 diabetic subjects 7/25 (28%) patients with abnormal ALT and 1/25 (4%) with normal ALT were HCV antibody positive. Among White Caucasian subjects 6/50 (12%) patients with abnormal LFTs and 0/50 with normal LFTs were HCV antibody positive and in Asians the prevalence was 2/25 (8%) and 0/25, respectively. This study suggests that persistent mild to moderate elevation of serum transaminases in a patient with Type 2 diabetes should not automatically be attributed to the metabolic disturbances of diabetes. Particularly in Afro‐Caribbean subjects, HCV infection is a major diagnostic consideration. The question of whether HCV infection itself may have a diabetogenic action is worthy of further investigation. 1995 Diabetes UK
This record has no associated files available for download.
More information
Published date: March 1995
Keywords:
Hepatitis C, Liver function tests, Type 2 Diabetes
Identifiers
Local EPrints ID: 486945
URI: http://eprints.soton.ac.uk/id/eprint/486945
ISSN: 0742-3071
PURE UUID: daaa9c77-7127-4f7d-a327-d707c202d7d8
Catalogue record
Date deposited: 08 Feb 2024 17:45
Last modified: 18 Mar 2024 04:01
Export record
Altmetrics
Contributors
Author:
H. Gray
Author:
T. Wreghitt
Author:
I. M. Stratton
Author:
G. J.M. Alexander
Author:
R. C. Turner
Author:
S. O'Rahilly
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics